Others, such as CCR4 (C–C chemokine receptor type 4) and TRBC (T-cell receptor beta constant), are also expressed in some T-ALL and can be potential targets for T-ALL immunotherapy (94, 95). The gene discussed is CCR4; the disease is acute lymphoblastic leukemia.